Management of Metastatic Clear Cell Renal Cell Carcinoma Guideline
An interview with Dr. Tian Zhang from UT Southwester Medical Center in Dallas, TX, author on "Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline." Dr. Zhang reviews the guideline...
21 Kesä 202212min
Systemic Therapy for Melanoma Rapid Recommendation Update
An interview with Dr. Pauline Funchain from Cleveland Clinic in Cleveland, OH, author on "Systemic Therapy for Melanoma: ASCO Guideline Rapid Recommendation Update." Dr. Funchain reviews recent eviden...
3 Kesä 20227min
Systemic Therapy for Advanced HER2-Positive Breast Cancer Guideline Update
An interview with Dr. Sharon Giordano from the University of Texas MD Anderson Cancer Center in Houston, TX, and Dr. Nancy Davidson from Fred Hutchinson Cancer Research Center and the University of Wa...
31 Touko 202213min
Management of Advanced HER2-Positive Breast Cancer and Brain Metastases Guideline Update
An interview with Dr. Naren Ramakrishna from Orlando Health Cancer Institute in Orlando, FL, and Dr. Carey Anders from Duke University in Durham, NC, co-chairs on "Management of Advanced Human Epiderm...
31 Touko 202214min
Exercise, Diet, and Weight Management During Cancer Treatment Guideline
An interview with Dr. Jennifer Ligibel from Dana Farber Cancer Institute in Boston, MA and Dr. Catherine Alfano from Northwell Health Cancer Institute and Feinstein Institutes for Medical Research in ...
16 Touko 202213min
Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline
An interview with Dr. David Schiff from the University of Virginia Medical Center in Charlottesville, VA, Dr. Michael Vogelbaum from Moffitt Cancer Center in Tampa, FL, and Dr. Vinai Gondi from Northw...
13 Touko 202213min
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer Guideline Update
An interview with Dr. Fabrice André from Institute Gustave Roussy in Paris, France, and Dr. Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, NY, authors on "Biomarkers for Adjuva...
19 Huhti 20229min
Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-risk, Early-stage Triple Negative Breast Cancer Rapid Recommendation Update
An interview with Dr. Lisa Carey from the University of North Carolina Lineberger Comprehensive Cancer Center in Chapel Hill, NC, panel member on "Use of Immune Checkpoint Inhibitor Pembrolizumab in t...
13 Huhti 20229min
